1. Song Y, Hou Z, Zhu L, Chen Y, Li J. Oxidative stress as a catalyst in prostate cancer progression: unraveling molecular mechanisms and exploring therapeutic interventions. Discov Oncol. 2025;16(1):457. | https://doi.org/10.1007/s12672-025-02245-4
2. Naiki‐Ito A, Naiki T, Takahashi S. Exploring experimental models of prostate cancer in chemoprevention: Oxidative stress as a key pathway to translational research. Pathol Int. 2025;75(3):131–44. https://doi.org/10.1111/pin.13509
3. Liu R, Lu J, Liu J, Liao Y, Guo Y, Shi P, et al. Macrophages in prostate cancer: dual roles in tumor progression and immune evasion. J Transl Med. 2025;23(1):615. https://doi.org/10.1186/s12967-025-06519-x
4. Lin M, Sun X, Lv L. New insights and options into the mechanisms and effects of combined targeted therapy and immunotherapy in prostate cancer. Mol Ther. 2023;29:91–106. https://doi.org/10.1016/j.omto.2023.04.007
5. Hosseini A, Kazemi N, Shadmehri S, Salehi OR. Lipid lowering effects of pilates training in women with breast cancer. Iran J Breast Dis. 2017;10(3):21–30.
6. Webber M, Li M, Cai C, Zou K. Effects of exercise training on prostate cancer: current evidence and potential molecular mechanisms. Adv Exerc Heal Sci. 2024;1(3):160–9 https://doi.org/10.1016/j.aehs.2024.08.003.
7. Houben LHP, Overkamp M, Van Kraaij P, Trommelen J, Van Roermund JGH, De Vries P, et al. Resistance exercise training increases muscle mass and strength in prostate cancer patients on androgen deprivation therapy. Med Sci Sports Exerc. 2022;55(4):614. https://doi.org/10.1249/mss.0000000000003095
8. Patel DI, Abuchowski K, Sheikh B, Rivas P, Musi N, Kumar AP. Exercise preserves muscle mass and force in a prostate cancer mouse model. Eur J Transl Myol. 2019;29(4):8520. https://doi.org/10.4081/ejtm.2019.8520
9. Malekpoor Z, Taghian F, Jalali Dehkordi K. The effect of aerobic exercise combined with the combination of gallic acid and kaempferol on neurogenesis caused by the side effects of paclitaxel in mice with breast cancer. J Isfahan Med Sch. 2023;41(722):427–37. https://doi.org/10.48305/jims.v41.i722.0427
10. Holghoomi R, Kiani MH, Rahdar A, Hashemi SM, Ferreira LFR, Fathi-karkan S. Nanoparticle-delivered gallic acid: A new frontier in cancer therapy. J Drug Deliv Sci Technol. 2024;101:106129. https://doi.org/10.1016/j.jddst.2024.106129
11. Meng R, Zhang Z. Gallic Acid Inhibits the Proliferation and Migration of Ovarian Cancer Cells via Inhibition of the PI3K‐AKT Pathway and Promoting M1‐Like Macrophage Polarization. Anal Cell Pathol. 2025;2025(1):3880719. https://doi.org/10.1155/ancp/3880719
12. Yazgan Y, Cinar R. Gallic acid enhances cisplatin-induced death of human laryngeal cancer cells by activating the TRPM2 channel. In: Doklady Biochemistry and Biophysics. Springer; 2025. p. 221–31. https://doi.org/10.1134/s1607672924601276
13. Malekpoor Z, Taghian F, Jalali DK. The effect of endurance training and consumption of gallic acid and kaempferol on the expression of ARC, VEGFα, HIF1α and CREB1 genes in mice with breast cancer treated with paclitaxel. 2024;22-40. http://dx.doi.org/10.61186/ijbd.17.1.22
14. Liu W, Zhu Y, Ye L, Zhu Y, Wang Y. Establishment of an orthotopic prostate cancer xenograft mouse model using microscope-guided orthotopic injection of LNCaP cells into the dorsal lobe of the mouse prostate. BMC Cancer. 2022;22(1):173. https://doi.org/10.1186/s12885-022-09266-0
15. McCullough DJ, Nguyen LM-D, Siemann DW, Behnke BJ. Effects of exercise training on tumor hypoxia and vascular function in the rodent preclinical orthotopic prostate cancer model. J Appl Physiol. 2013;115(12):1846–54. https://doi.org/10.1152/japplphysiol.00949.2013
16. Ojo OA, Rotimi DE, Ojo AB, Ogunlakin AD, Ajiboye BO. Gallic acid abates cadmium chloride toxicity via alteration of neurotransmitters and modulation of inflammatory markers in Wistar rats. Sci Rep. 2023;13(1):1577. https://doi.org/10.1038/s41598-023-28893-6
17. Maxwell PJ, McKechnie M, Armstrong CW, Manley JM, Ong CW, Worthington J, et al. Attenuating adaptive VEGF-A and IL8 signaling restores durable tumor control in AR antagonist–treated prostate cancers. Mol Cancer Res. 2022;20(6):841–53. https://doi.org/10.1158/1541-7786.mcr-21-0780
18. Kim SJ, Uehara H, Karashima T, Mccarty M, Shih N, Fidler IJ. Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice. Neoplasia. 2001;3(1):33–42. https://doi.org/10.1038/sj.neo.7900124
19. Rusu L, Mihai TA, Schenker RA, Marin MI, Schenker M, Streba CT, et al. The effect of physical exercises on TNF-α, IL-6, and IL-8 cytokines expression and NK cells in cancer. Rom J Morphol Embryol. 2025;66(1):89. https://doi.org/10.47162/rjme.66.1.08
20. Sun Y, Ma Y, Shi L, Liu T, Dong Y, Jin Q. The impact and molecular mechanisms of exercise in cancer therapy. Curr Issues Mol Biol. 2025;47(5):374. https://doi.org/10.3390/cimb47050374
21. Kazemi AR, Agha Alinejad H, Eslami R, Ehsan P, Baghaei R, Dabaghzadeh R, et al. Investigating the effect of endurance training on tumor level of IL-8 and serum level of IL-17 in female mice with breast cancer. J Adv Biomed Sci. 2015;5(3):347–55. https://dor.isc.ac/dor/20.1001.1.22285105.2015.5.3.10.9
22. Liu Z, Ke S, Wan Y. miR-126: a bridge between cancer and exercise. Cancer Cell Int. 2025;25(1):145. https://doi.org/10.1186/s12935-025-03784-0
23. Kang DY, Bae SW, Jang K-J. Natural bioactive gallic acid shows potential anticancer effects by inhibiting the proliferation and invasiveness behavior in human embryonic carcinoma cells. Mol Med Rep. 2025;31(6):151. https://doi.org/10.3892/mmr.2025.13516
24. He Z, Chen AY, Rojanasakul Y, Rankin GO, Chen YC. Gallic acid, a phenolic compound, exerts anti-angiogenic effects via the PTEN/AKT/HIF-1α/VEGF signaling pathway in ovarian cancer cells. Oncol Rep. 2016;35(1):291–7. https://doi.org/10.3892/or.2015.4354
25. Jiang Y, Pei J, Zheng Y, Miao Y, Duan B, Huang L. Gallic acid: A potential anti-cancer agent. Chin J Integr Med. 2022;28(7):661–71. https://doi.org/10.1007/s11655-021-3345-2